David A Perez-Martinez
Overview
Explore the profile of David A Perez-Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
165
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matias-Guiu J, Alvarez-Sabin J, Botia E, Casado-Naranjo I, Castellanos M, Frank A, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):207-217.
PMID: 39497319
Background: A deep knowledge of the healthcare system and the organization of neurology departments is important for planning and optimizing changes to facilitate the successful implementation of anti-amyloid antibodies treatments....
2.
Saposnik G, Sanchez-Benavidez G, Garcia-Arcelay E, Franco-Macias E, Bensi C, Carmelingo S, et al.
Neurol Ther
. 2023 Mar;
12(3):995-1006.
PMID: 36952172
Introduction: The current therapeutic landscape of Alzheimer's disease (AD) is evolving rapidly. Our treatment options include new anti-amyloid-β protein disease-modifying therapies (DMTs) that decrease cognitive decline in patients with early...
3.
Perez-Lopez C, Hernandez-Vara J, Caballol N, Bayes A, Buongiorno M, Lopez-Ariztegui N, et al.
Front Neurol
. 2022 Jun;
13:835249.
PMID: 35651347
Background: For specialists in charge of Parkinson's disease (PD), one of the most time-consuming tasks of the consultations is the assessment of symptoms and motor fluctuations. This task is complex...
4.
Rodriguez-Molinero A, Hernandez-Vara J, Minarro A, Perez-Lopez C, Bayes-Rusinol A, Martinez-Castrillo J, et al.
BMJ Open
. 2021 Jul;
11(7):e045272.
PMID: 34281918
Introduction: In recent years, multiple studies have aimed to develop and validate portable technological devices capable of monitoring the motor complications of Parkinson's disease patients (Parkinson's Holter). The effectiveness of...
5.
Martin-Jimenez P, Munoz-Garcia M, Seoane D, Roca-Rodriguez L, Garcia-Reyne A, Lalueza A, et al.
J Alzheimers Dis
. 2020 Oct;
78(4):1367-1372.
PMID: 33074239
We analyzed the frequency of cognitive impairment (CI) in deceased COVID-19 patients at a tertiary hospital in Spain. Among the 477 adult cases who died after admission from March 1...
6.
Rodriguez-Molinero A, Perez-Lopez C, Sama A, De Mingo E, Rodriguez-Martin D, Hernandez-Vara J, et al.
JMIR Rehabil Assist Technol
. 2018 Apr;
5(1):e8.
PMID: 29695377
Background: A new algorithm has been developed, which combines information on gait bradykinesia and dyskinesia provided by a single kinematic sensor located on the waist of Parkinson disease (PD) patients...
7.
Villarejo-Galende A, Llamas-Velasco S, Gomez-Grande A, Puertas-Martin V, Contador I, Sarandeses P, et al.
J Neurol
. 2016 Nov;
264(1):121-130.
PMID: 27815682
Primary progressive aphasia (PPA) is considered a heterogeneous syndrome, with different clinical subtypes and neuropathological causes. Novel PET biomarkers may help to predict the underlying neuropathology, but many aspects remain...
8.
Olazaran J, Gil-de-Gomez L, Rodriguez-Martin A, Valenti-Soler M, Frades-Payo B, Marin-Munoz J, et al.
J Alzheimers Dis
. 2015 Feb;
45(4):1157-73.
PMID: 25649659
Accurate blood-based biomarkers of Alzheimer's disease (AD) could constitute simple, inexpensive, and non-invasive tools for the early diagnosis and treatment of this devastating neurodegenerative disease. We sought to develop a...
9.
Rodriguez-Molinero A, Sama A, Perez-Martinez D, Perez Lopez C, Romagosa J, Bayes A, et al.
JMIR Mhealth Uhealth
. 2015 Feb;
3(1):e9.
PMID: 25648406
Background: Patients with severe idiopathic Parkinson's disease experience motor fluctuations, which are often difficult to control. Accurate mapping of such motor fluctuations could help improve patients' treatment. Objective: The objective...
10.
Rodriguez-Molinero A, Perez-Martinez D, Catala A, Cabestany J, Yuste A
Med Hypotheses
. 2009 Jan;
72(4):430-3.
PMID: 19141365
Most recent therapeutic solutions to treat Parkinson's disease seek continuous administration of dopaminergic agonists, as for example rigotine patches or apomorphine infusion pumps. Such drug-delivery devices are aimed at preventing...